Fig. 1From: Patients with hepatic breast cancer metastases demonstrate highly specific profiles of matrix metalloproteinases MMP-2 and MMP-9 after SIRT treatment as compared to other primary and secondary liver tumoursWorkflow. The scheme summarises how the entire study has been designed and experimental approach performed in the patients poolBack to article page